Outpatient Ketamine Infusion for Chronic Neuropathic Pain and PTSD
Outpatient ketamine infusion for active-duty service members, veterans, and retirees with chronic neuropathic pain and PTSD.
This is an interventional study — the research team administers the treatment under a controlled, IRB-approved protocol. Participation never happens outside that protocol.
- Substance
- Ketamine
- Status
- Recruiting now
- Conditions
- PTSD, Neuropathic Pain
- Who can join
- Active duty, veterans & retirees
- Where
- Texas
- Run by
- Military pain research (M. Salas, PhD)
- Registry ID
- NCT06414356 ↗
How to join this study
Call or email the study team directly. You do not go through Psychedelic Vets — we just make the door easier to find.
Contact details as published by the sponsor, last verified 2025-02. People move on — if this doesn't reach anyone, check ClinicalTrials.gov.
What taking part involves
0.5 mg/kg/hr The total amount of ketamine for each participant is dependent on their body weight in kg per ideal body weight (IBW) formula. This total ketamine dose will be injected into one 250 ml normal saline 0.9% solution with a rate of 62.5 ml/hr over four hours or until the contents of the bag are infused and flushed with 20 ml of normal saline
0.50 mg/kg/hr ketamine + 750 mg/hr Mg
750 mg/hr
Who can join
Listed as the research team wrote them. This is not a decision about you — only the study team can say whether you are eligible, and the only way to find out is to ask them.
What the study is looking for
- 18-70 years old with Chronic Neuropathic Pain \>= 3 months
- Biologic male or biologic female
- Women of childbearing age will be included if there are no plans of pregnancy within the study period, the participant agrees to actively utilize contraception throughout the study, and agrees to pregnancy tests
- Active Duty, Veterans, and retirees
- Ketamine naïve for 1 year
- Moderate Neuropathic pain Scale 4-7
What would rule you out
- Cognitive dysfunction
- Psychiatric illness involving psychosis
- Neurocognitive disorder
- Patients with Traumatic Brain Injury (TBI)
- Acute cardiovascular disease or poorly controlled hypertension
- Untreated or uncontrolled thyroid disease
- Hyperthyroidism
- Severe liver or renal disease
- Renal impairment
- History of recent heart attack, vascular disease, or any other medical condition that may be deemed by a provider as a contraindication to receiving ketamine
- Active substance abuse
- Pregnant or lactating
- Patients who are planning to become pregnant within 12 weeks of treatment completion
- Elevated Blood Pressure/hypertension
- Known hypersensitivity to Ketamine
- Hemodynamic instability
- Respiratory depression
- Use of Theophylline or Aminophylline, Sympathomimetics and Vasopressin,
- Use of Benzodiazepines
- A history of drug abuse or dependence
- Active risk of substance use
- Patients who are not able to abide by the pre-treatment and posttreatment clinical protocol, such as food intake, abstaining from certain medications, unable to remain in the clinic for a minimum of 1 hour for observation, and cannot provide the name and phone number of the party who will pick them up post-treatment
You enroll directly with the research team through their own official page and IRB-approved consent process. Psychedelic Vets does not run this study or collect any of your health information.
Study data is sourced from ClinicalTrials.gov (U.S. National Library of Medicine) and verified university/nonprofit sources. This page is educational and is not medical advice or an endorsement. Details can change — always confirm on the official page above. ← Back to all studies
